FDA NDC Directory · JSON-LD · Markdown

Rybrevant Faspro

NDC 57894-514 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameAMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)
Labeler / ManufacturerJanssen Biotech, Inc.
Marketing categoryBiologic License Application · App BLA761433
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsAMIVANTAMAB (2240 mg/14mL)
HYALURONIDASE (HUMAN RECOMBINANT) (28000 mg/14mL)
Marketing started20251219
Package count1

External sources

Source: openFDA. Public-domain (CC0).